AXIS Capital Holdings Ltd.
|
|
- Bruce York
- 5 years ago
- Views:
Transcription
1 March 20, 2015 AXIS Capital Holdings Ltd. Current Recommendation SUMMARY DATA NEUTRAL Prior Recommendation Outperform Date of Last Change 07/24/2013 Current Price (03/19/15) $51.45 Target Price $ Week High $ Week Low $43.15 One-Year Return (%) Beta 0.78 Average Daily Volume (sh) 704,569 Shares Outstanding (mil) 101 Market Capitalization ($mil) $5,196 Short Interest Ratio (days) 1.56 Institutional Ownership (%) 88 Insider Ownership (%) 3 (AXS-NYSE) SUMMARY AXIS Capital s fourth-quarter earnings missed the Zacks Consensus Estimate and declined year over year. A soft interest rate environment weighed on investment results. Also, heightened competition, especially in Reinsurance, affected the bottom line. Nonetheless, strong underwriting results driven by low cat activity, favorable reserve development and a broadly diversified, well-constructed portfolio of risks were the positives. The company recently agreed to a merger with PartnerRe Ltd. Post-merger, the combined entity will be among the top-five global reinsurers in terms of premiums. Riding on its strong capital position, the board increased the quarterly dividend by 7%. The accident and health business continues to show strength. The Lloyd's unit continues to pave way for improvement while its third-party capital initiative, AXIS Ventures is expected to expand on its capabilities in its second year of operations. However, escalating expanses have been hurting the margins. Risk Level * Low, Type of Stock Large-Value Industry Ins-Prop&Caslty Zacks Industry Rank * 86 out of 267 ZACKS CONSENSUS ESTIMATES Revenue Estimates (In millions of $) Q1 Q2 Q3 Q4 Year (Mar) (Jun) (Sep) (Dec) (Dec) Annual Cash Dividend $1.16 Dividend Yield (%) Yr. Historical Growth Rates Sales (%) 7.0 Earnings Per Share (%) 14.0 Dividend (%) 6.1 using TTM EPS 9.7 using 2015 Estimate 11.4 using 2016 Estimate 11.0 Zacks Rank *: Short Term 1 3 months outlook 3 - Hold * Definition / Disclosure on last page ,028 A 1,046 A 1,045 A 1,078 A 4,196 A ,042 A 1,117 A 1,118 A 1,036 A 4,347 A ,051 E 1,066 E 1,081 E 1,090 E 4,288 E ,430 E Earnings Per Share Estimates (EPS is operating earnings before non-recurring items, but including employee stock options expenses) Q1 Q2 Q3 Q4 Year (Mar) (Jun) (Sep) (Dec) (Dec) 2013 $2.21 A $0.43 A $1.74 A $1.41 A $5.49 A 2014 $1.24 A $1.63 A $1.27 A $1.18 A $5.32 A 2015 $1.15 E $1.25 E $0.87 E $1.25 E $4.52 E 2016 $4.69 E Projected EPS Growth - Next 5 Years % Zacks Investment Research, All Rights reserved North Canal Street, Chicago IL 60606
2 OVERVIEW Incorporated in Nov 2001, AXIS Capital was one of the several insurance carriers formed to take advantage of the enhanced insurance demand following the 9/11 terrorist attacks. Bermuda-based AXIS Capital is a global provider of specialty lines insurance and treaty reinsurance. The company operates in Bermuda, the U.S., Singapore, and Europe. The company was listed on the NYSE in Jul AXIS Capital has two reportable segments: The Insurance segment offers a diverse portfolio of primary and excess products, ranging from property, marine, energy and casualty insurance to professional lines, aviation, terrorism, credit and political risk, customized insurance programs with managing general agency (MGA) partners and other specialized coverage. The Reinsurance segment provides property and casualty treaty reinsurance to insurance companies predominantly on an excess-of-loss basis. Since inception, this segment has been a reinsurer of natural and man-made catastrophe exposures as well as traditional property business, professional lines, liability, motor, credit/bond and other specialty risks globally. On Jan 27, 2015, AXIS Capital and PartnerRe Ltd. entered into a merger agreement. The deal is expected to culminate by the second half of 2015, once the regulatory and shareholder approvals are attained. REASONS TO BUY Given the intensely competitive environment that the reinsurance industry is facing amid declining premiums, AXIS Capital and PartnerRe Ltd. announced their stock swap merger agreement to guard against future losses and reserve shortfalls. The merged entity is presently worth about $11 billion. Post amalgamation, the new entity would have gross premiums of over $10 billion, an investment portfolio of over $33 billion and total capital of more than $14 billion, along with a $2.5 billion worth of underwriting business. AXIS estimates its global specialty insurance business to benefit immediately from additional revenues and expanded geographic distribution. These figures suggest that the PartnerRe-AXIS fusion will be ranked as one of the top-five global reinsurers in terms of premiums. This would give it a huge competitive advantage. PartnerRe and AXIS expect pre-tax cost synergies worth $200 million from the merger within the first 1.5 years only, with accretion to earnings as well as on return on equity (ROE), New business opportunities across AXIS Capital s lines of business and geography have helped the company achieve growth in premium writings. The Insurance segment in particular, continues to drive solid numbers. Consolidated net earned premium increased 12.5% in 2011, 3% in 2012, 8.5% in 2013 and 4.4% in While insurance premium benefitted from expansion in the accident and health lines, growth in liability lines and the positive impact of the reductions in the professional and liability ceded reinsurance programs implemented in 2013, the reinsurance segment benefitted from growth in liability and motor lines, continued expansion of the agriculture business and an increase in professional lines. AXIS Capital has also been benefiting from rate increases that finally leveled off but will continue to benefit from solid fundamentals and growth opportunities. AXIS Capital s new syndicate at Lloyds, Axa syndicate 1686, continues to perform well. The company has also started to weigh the opportunities for AXIS Ventures, the new third-party capital initiative. In addition, its initiatives including re-entry into U.S. primary casualty, and weather and commodities business is contributing to results. The company expects to capitalize on the new opportunities provided by its Equity Research AXS Page 2
3 global licenses and widespread distribution network. Management also expects gross premiums written in 2015 to improve from the 2014 level. Riding on the back of increasing premiums, top line grew 7% in 2011, 3.3% in 2012, 6.9% in 2013 and 3.6% in This top-line momentum is expected to be sustained on the back of new strategic changes made by the company across its reinsurance, purchasing and insurance segment. For example, a decrease in quota share session rates in professional lines and liability books and cost minimization of AXIS Capital s property for risk and property cat-protections are expected to drive up revenues for the company. AXIS Capital continues to boost its shareholder value through share buybacks and dividend hikes. The company has been continually increasing dividends each year. The approval of a 7.4% dividend hike in Dec 2014 marked the 11 th consecutive year of payout increase. The company increased dividend at an 11-year CAGR of about 14%. The dividend of $0.29 per share currently yields 2.26%, which is better than the sector yield of 1.75%. With respect to share buybacks, the company spent $543 million on buying back 11.8 million shares in Moreover, in Dec 2014, the board of directors of AXIS Capital approved a new share repurchase authorization of $750 million that is due to expire at the end of 2016 but suspended the same till the closure of the merger with PartnerRe. The company has returned about $661 million in 2014 to its shareholders in the form of dividends and buybacks, representing 117% of operating income. We believe a strong cash balance and retained earnings as well as solid bottom line growth owing to better performances across the segments will continue to support AXIS Capital s share buyback activities and dividend payouts. The company envisions returning near about 100% of annual operating earnings to through dividends and share repurchases. AXIS Capital has witnessed a U -shaped investment income trend for the last few years. The downward trend commenced with 12.4% decline in 2010 and a further 10.9% in The trend changed its course with net investment income improving 5.1% in 2012 and again 7.4% during 2013 to $409.3 million. The increase was mainly due to rise in other investment income, which in turn resulted from the company s higher investments in hedge funds. However, 2014 witnessed a 16% decline in net investment income due to lower returns from hedge funds and reflected lower returns from the global equity markets during Nonetheless, we expect the investment portfolio to perform strongly despite the prevailing soft interest rate environment. REASONS TO SELL AXIS Capital is highly exposed to losses resulting from natural disasters, man-made catastrophes and other catastrophic events. The severe and frequent occurrence of such events caused an underwriting loss of $327.2 million for the company in 2011 compared with $409 million of underwriting income reported in witnessed underwriting income of approximately $263 million. Underwriting income during 2013 inched down nearly 1.2% but improved 19.7% in 2014 on low cat activity, favorable reserve development and a well-managed portfolio of risks. Combined ratio deteriorated 940 basis points (bps) to 88.7% in 2010 and 2,360 bps to 112.3% in However, the same improved 1,610 bps to 96.2% in 2012 and 520 bps to 91% in 2013 but deteriorated 60 bps to 91.6% in Exposure to catastrophe activities will always remain a concern because of the uncertainty of occurrence as well as the magnitude of impact. We believe that increasing competition in the insurance industry can result in slow growth and lower profitability for AXIS Capital. The company competes with international and regional peers that are based in the U.S., Europe, Bermuda and other locations, as well as with new entrants to the industry. Some of these peers have greater marketing, financial and management resources than AXIS Equity Research AXS Page 3
4 Capital. We also believe that recent alternative products issued by capital market participants to replace reinsurance products can result in lower submissions, weak premium rates, higher costs of customer acquisition and retention, and less favorable terms and conditions of policies for the company. Also, operational results are subject to the risk of currency fluctuations. AXIS Capital has been witnessing rising expenses over the last few years. Total expense of the company increased 16.7% year over year in 2010 and 40.8% in Although 2012 exhibited a slight improvement in the expense level, it again increased 2.5% year over year in 2013 and 1.6% in The increase was primarily due to higher net losses and loss expenses, general and administrative expenses, higher acquisition costs and increase in interest expense and financing costs. This gradual increase in the expense level is affecting the operating margin expansion of the company. Higher expenses have been eating into the margin, which eroded from 25.2% in 2010 to 19.1% in If expenses continue to increase and the magnitude of rise in revenues fails to exceed the magnitude of increase in expenses, operation margin expansion will be affected. AXIS Capital derives a large portion of its revenues from a limited number of brokers. About 56% of gross premiums written in 2014 came from Marsh & McLennan Companies, Inc., including its subsidiary Guy Carpenter & Company, Inc., Aon Corporation and Willis Group Holdings Ltd. Failure to maintain underwriting and claim services quality, deterioration in financial strength ratings or brokers buying stakes in insurance and reinsurance companies and hence competing directly with AXIS might result in loss of business from these brokers. This in turn will weigh on the top line of the company. RECENT NEWS AXIS Capital Declares Dividend Feb 20, 2015 The board of directors of AXIS Capital declared a quarterly dividend of $0.29 per share. The dividend is payable on Apr 15, 2015 to the shareholders of record at the close of business on Mar 31. AXIS Capital Q4 Earnings Miss on Soft Investment Results Feb 3, 2015 AXIS Capital Holdings Limited s fourth-quarter 2014 earnings per share of $1.18 missed the Zacks Consensus Estimate by a couple of cents. Earnings declined 16% year over year. A soft interest rate environment weighed on investment results. Also, heightened competition, especially in Reinsurance, affected the bottom line. Nonetheless, strong underwriting results driven by low cat activity, favorable reserve development and a broadly diversified, well-constructed portfolio of risks were the breathers. Including net realized investment loss of $0.01 per share and foreign exchange loss of $0.43 per share, AXIS Capital reported net income of $1.60 per share, up 5.3% year over year. Operational Update A 31% year-over-year drop in net investment income overshadowed a 1.8% rise in premiums earned, resulting in a 51% drop in total revenue. Revenues of $1.04 billion also missed the Zacks Consensus Estimate of $1.06 billion. Total expense in the quarter decreased about 5.8% year over year to $48 million. Equity Research AXS Page 4
5 Underwriting income of AXIS Capital increased 20% year over year to $112.7 million. Combined ratio improved 100 basis points (bps) to 91.5%. Full-Year 2014 Review AXIS Capital s operating income of $5.32 per share missed the Zacks Consensus Estimate by 0.4% and declined 3% over Net income came in at $7.29, up 23% over Revenues improved 2.3% year over year to $4.2 billion. Segment Result Insurance Segment: Gross premiums written increased 3% year over year driven by better performing property lines, and liability lines fueled by growing U.S. excess casualty markets. Net premiums earned increased about 3% year over year owing to improvement in accident and health business lines. Underwriting income increased more than threefold to $34 million. Combined ratio improved 510 bps year over year to 92.7%. Reinsurance Segment: Gross premiums written in the quarter decreased 7% year over year to $138 million, largely due to soft performing professional and property lines. Net premiums earned increased 2.8% year over year. While underwriting income decreased 6%, combined ratio improved 170 bps year over year. Financial Update AXIS Capital exited the quarter with cash and cash equivalents of $1.3 billion, up 22% from the 2013-end level. Total capitalization at quarter end was $6.8 billion, including $1 billion of long-term debt and $0.6 billion of preferred equity. The company repaid $500 million of 5.75% senior unsecured notes. Cash flows from operations of $887 million decreased 19.4% year over year. Book value per share was $50.63 on Dec 31, 2014, up 11% year over year. Capital Deployment During the reported quarter, AXIS Capital repurchased 1.5 million shares for $75 million taking the full year tally to 11.8 million shares bought back for $543 million. The board increased the quarterly dividend by 7% to $0.29 per share. AXIS Capital-PartnerRe Ink Merger Deal Jan 27, 2015 PartnerRe Ltd. and AXIS Capital announced their intention to join in a stock swap merger agreement. The deal is expected to culminate by the second half of Equity Research AXS Page 5
6 AXIS shareholders will receive one share of the merged company against each existing share, while PartnerRe investors will own 2.18 shares of the new entity for each of its present share. Accordingly, the swap will give PartnerRe a 51.6% stake in the merged company, whereas AXIS will have the remaining 48.4%. The merged entity is presently worth about $11 billion. Moreover, post amalgamation, the new entity would have gross premiums of over $10 billion, an investment portfolio of over $33 billion and total capital of more than $14 billion, along with a $2.5 billion worth of underwriting business. These figures estimate the combined PartnerRe-AXIS to be among the top-five global reinsurers in terms of premiums. PartnerRe and AXIS expect pre-tax cost synergies worth $200 million from the merger within the first 1.5 years only. Equity Research AXS Page 6
7 VALUATION AXIS Capital shares currently trade at 11.4x our 2015 earnings estimate, a 25% discount to the industry average of 15.2x. On a price-to-book basis, the shares are trading at 1.0x, a 23.1% discount to the industry average of 1.3x. The valuation on a price-to-book basis looks attractive, given the trailing 12- month ROE of 11.0% substantially higher than the industry average of 9.3%. Our six-month target price of $54.00 equates to 11.9x our earnings estimate for Combined with the annual dividend of $1.16, this price target implies an expected total return of 6.1% over that period. Key Indicators F1 F2 Est. 5-Yr EPS Gr% P/CF 5-Yr High 5-Yr Low AXIS Capital Holdings Ltd. (AXS) Industry Average S&P First American Financial Corporation (FAF) Cincinnati Financial Corp. (CINF) NA AmTrust Financial Services, Inc. (AFSI) Arch Capital Group Ltd. (ACGL) TTM is trailing 12 months; F1 is 2015 and F2 is 2016, CF is operating cash flow P/B Last Qtr. P/B 5-Yr High P/B 5-Yr Low ROE D/E Last Qtr. Div Yield Last Qtr. EV/EBITDA AXIS Capital Holdings Ltd. (AXS) Industry Average S&P Equity Research AXS Page 7
8 Earnings Surprise and Estimate Revision History Equity Research AXS Page 8
9 DISCLOSURES & DEFINITIONS The analysts contributing to this report do not hold any shares of AXS. The EPS and revenue forecasts are the Zacks Consensus estimates. Additionally, the analysts contributing to this report certify that the views expressed herein accurately reflect the analysts personal views as to the subject securities and issuers. Zacks certifies that no part of the analysts compensation was, is, or will be, directly or indirectly, related to the specific recommendation or views expressed by the analyst in the report. Additional information on the securities mentioned in this report is available upon request. This report is based on data obtained from sources we believe to be reliable, but is not guaranteed as to accuracy and does not purport to be complete. Because of individual objectives, the report should not be construed as advice designed to meet the particular investment needs of any investor. Any opinions expressed herein are subject to change. This report is not to be construed as an offer or the solicitation of an offer to buy or sell the securities herein mentioned. Zacks or its officers, employees or customers may have a position long or short in the securities mentioned and buy or sell the securities from time to time. Zacks uses the following rating system for the securities it covers. Outperform- Zacks expects that the subject company will outperform the broader U.S. equity market over the next six to twelve months. Neutral- Zacks expects that the company will perform in line with the broader U.S. equity market over the next six to twelve months. Underperform- Zacks expects the company will under perform the broader U.S. Equity market over the next six to twelve months. The current distribution of Zacks Ratings is as follows on the 1133 companies covered: Outperform %, Neutral %, Underperform 8.8%. Data is as of midnight on the business day immediately prior to this publication. Our recommendation for each stock is closely linked to the Zacks Rank, which results from a proprietary quantitative model using trends in earnings estimate revisions. This model is proven most effective for judging the timeliness of a stock over the next 1 to 3 months. The model assigns each stock a rank from 1 through 5. Zacks Rank 1 = Strong Buy. Zacks Rank 2 = Buy. Zacks Rank 3 = Hold. Zacks Rank 4 = Sell. Zacks Rank 5 = Strong Sell. We also provide a Zacks Industry Rank for each company which provides an idea of the near-term attractiveness of a company s industry group. We have 264 industry groups in total. Thus, the Zacks Industry Rank is a number between 1 and 264. In terms of investment attractiveness, the higher the rank the better. Historically, the top half of the industries has outperformed the general market. In determining Risk Level, we rely on a proprietary quantitative model that divides the entire universe of stocks into five groups, based on each stock s historical price volatility. The first group has stocks with the lowest values and are deemed Low Risk, while the 5 th group has the highest values and are designated High Risk. Designations of Below-Average Risk, Average Risk, and Above-Average Risk correspond to the second, third, and fourth groups of stocks, respectively. Equity Research AXS Page 9
Cincinnati Financial Corp.
February 06, 2015 Cincinnati Financial Corp. NEUTRAL Current Recommendation Prior Recommendation Outperform Date of Last Change 02/10/2014 Current Price (02/05/15) $51.89 Target Price $54.00 (CINF-NASDAQ)
More information(PGR-NYSE) Risk Level *
March 18, 2015 Progressive Corp. Current Recommendation NEUTRAL Prior Recommendation Outperform Date of Last Change 05/19/2013 Current Price (03/17/15) $27.03 Target Price $28.00 SUMMARY DATA (PGR-NYSE)
More informationPrudential Financial Inc.
February 06, 2015 Prudential Financial Inc. Current Recommendation NEUTRAL Prior Recommendation Outperform Date of Last Change 04/03/2014 Current Price (02/05/15) $75.32 Target Price $79.00 SUMMARY DATA
More informationSUMMARY. Risk Level *
February 26, 2015 The Home Depot, Inc. Current Recommendation Earnings Update: Home Depot Tops Q4 Earnings & Revenues, Guides FY15 SUMMARY DATA NEUTRAL Prior Recommendation Underperform Date of Last Change
More informationGenworth Financial Inc.
February 12, 2015 Genworth Financial Inc. Current Recommendation Prior Recommendation Neutral Date of Last Change 08/22/2014 Current Price (02/11/15) $8.33 Target Price $7.50 SUMMARY DATA UNDERPERFORM
More information(SEIC-NASDAQ) Risk Level *
March 20, 2015 SEI Investments Co. Current Recommendation NEUTRAL Prior Recommendation Outperform Date of Last Change 09/30/2013 Current Price (03/19/15) $43.74 Target Price $46.00 SUMMARY DATA (SEIC-NASDAQ)
More informationSVB Financial Group NEUTRAL ZACKS CONSENSUS ESTIMATES (SIVB-NASDAQ) SUMMARY
January 02, 2015 SVB Financial Group Current Recommendation NEUTRAL Prior Recommendation Outperform Date of Last Change 01/02/2015 Current Price (01/01/15) $116.07 Target Price $122.00 SUMMARY DATA (SIVB-NASDAQ)
More informationTorchmark Corp. NEUTRAL ZACKS CONSENSUS ESTIMATES (TMK-NYSE) SUMMARY
March 12, 2015 Torchmark Corp. Current Recommendation NEUTRAL Prior Recommendation Underperform Date of Last Change 07/20/2006 Current Price (03/11/15) $53.41 Target Price $56.00 SUMMARY DATA (TMK-NYSE)
More informationFederated Investors, Inc.
March 04, 2015 Federated Investors, Inc. Current Recommendation Prior Recommendation Underperform Date of Last Change 11/30/2014 Current Price (03/03/15) $33.52 Target Price $35.00 NEUTRAL SUMMARY (FII-NYSE)
More informationCullen/Frost Bankers, Inc.
December 26, 2014 Cullen/Frost Bankers, Inc. Current Recommendation SUMMARY DATA NEUTRAL Prior Recommendation Neutral Date of Last Change 11/30/2001 Current Price (12/25/14) $70.74 Target Price $74.00
More informationSUMMARY. Risk Level *
March 17, 2015 XL Group plc (XL-NYSE) NEUTRAL Current Recommendation Prior Recommendation Outperform Date of Last Change 08/22/2013 Current Price (03/16/15) $36.78 Target Price $39.00 SUMMARY XL Group
More informationWells Fargo & Company
March 04, 2015 Wells Fargo & Company Current Recommendation SUMMARY DATA NEUTRAL Prior Recommendation N/A Date of Last Change 04/07/2000 Current Price (03/03/15) $55.45 Target Price $58.00 52-Week High
More information(RHI-NYSE) SUMMARY. Risk Level *
March 04, 2015 Robert Half International Inc. Current Recommendation SUMMARY DATA NEUTRAL Prior Recommendation Outperform Date of Last Change 08/19/2012 Current Price (03/03/15) $62.70 Target Price $66.00
More informationPentair plc NEUTRAL ZACKS CONSENSUS ESTIMATES (PNR-NYSE)
March 20, 2015 Pentair plc (PNR-NYSE) Current Recommendation SUMMARY DATA NEUTRAL Prior Recommendation Underperform Date of Last Change 01/12/2014 Current Price (03/19/15) $64.38 Target Price $68.00 52-Week
More informationCIT Group Inc. NEUTRAL ZACKS CONSENSUS ESTIMATES (CIT-NYSE)
February 24, 2015 CIT Group Inc. (CIT-NYSE) Current Recommendation SUMMARY DATA NEUTRAL Prior Recommendation Outperform Date of Last Change 02/18/2015 Current Price (02/23/15) $46.13 Target Price $48.50
More informationAvery Dennison Corporation
March 20, 2015 Avery Dennison Corporation Current Recommendation NEUTRAL Prior Recommendation Outperform Date of Last Change 09/26/2013 Current Price (03/19/15) $53.00 Target Price $56.00 SUMMARY DATA
More informationInvesco Ltd. NEUTRAL ZACKS CONSENSUS ESTIMATES (IVZ-NYSE)
March 10, 2015 Invesco Ltd. (IVZ-NYSE) Current Recommendation SUMMARY DATA NEUTRAL Prior Recommendation Underperform Date of Last Change 10/03/2012 Current Price (03/09/15) $40.40 Target Price $42.00 52-Week
More informationTE Connectivity Ltd. (TEL-NYSE) Analyst Note
January 30, 2015 TE Connectivity Ltd. (TEL-NYSE) Analyst Note Current Recommendation SUMMARY DATA NEUTRAL Prior Recommendation Underperform Date of Last Change 12/30/2012 Current Price (01/29/15) $67.57
More informationCanadian Natural Resources Ltd.
March 12, 2015 Canadian Natural Resources Ltd. (CNQ-NYSE) Current Recommendation Prior Recommendation Underperform Date of Last Change 06/30/2013 Current Price (03/11/15) $28.82 Target Price $30.00 NEUTRAL
More informationSUMMARY. Risk Level *
March 20, 2015 Aon Plc NEUTRAL Current Recommendation Prior Recommendation Outperform Date of Last Change 06/18/2012 Current Price (03/19/15) $98.91 Target Price $104.00 SUMMARY (AON-NYSE) Aon s fourth-quarter
More informationFirst Republic Bank NEUTRAL ZACKS CONSENSUS ESTIMATES (FRC-NYSE) SUMMARY
March 06, 2015 First Republic Bank Current Recommendation SUMMARY DATA NEUTRAL Prior Recommendation Neutral Date of Last Change 04/14/2011 Current Price (03/05/15) $57.70 Target Price $61.00 52-Week High
More informationPitney Bowes Inc. (PBI-NYSE) Analyst Note
February 03, 2015 Pitney Bowes Inc. (PBI-NYSE) Analyst Note Current Recommendation Prior Recommendation Outperform Date of Last Change 05/01/2014 Current Price (02/02/15) $22.26 Target Price $23.00 NEUTRAL
More informationCH Robinson Worldwide Inc.
March 20, 2015 CH Robinson Worldwide Inc. Current Recommendation NEUTRAL Prior Recommendation Underperform Date of Last Change 08/22/2013 Current Price (03/19/15) $75.16 Target Price $79.00 SUMMARY DATA
More informationHibbett Sports, Inc. NEUTRAL ZACKS CONSENSUS ESTIMATES (HIBB-NASDAQ)
December 12, 2014 Hibbett Sports, Inc. Current Recommendation SUMMARY DATA NEUTRAL Prior Recommendation Underperform Date of Last Change 06/17/2014 Current Price (12/11/14) $48.16 Target Price $51.00 52-Week
More informationAmerican Capital Agency Corp.
January 15, 2015 American Capital Agency Corp. (AGNC-NASDAQ) Current Recommendation Prior Recommendation Neutral Date of Last Change 10/15/2014 Current Price (01/14/15) $21.53 Target Price $26.00 SUMMARY
More informationMagna International Inc.
February 26, 2015 Magna International Inc. Current Recommendation SUMMARY DATA NEUTRAL Prior Recommendation Outperform Date of Last Change 07/09/2014 Current Price (02/25/15) $110.01 Target Price $116.00
More informationSimon Property Group Inc. (SPG-NYSE) Analyst Note
February 02, 2015 Simon Property Group Inc. (SPG-NYSE) Analyst Note NEUTRAL Current Recommendation Prior Recommendation Underperform Date of Last Change 09/11/2014 Current Price (01/30/15) $198.66 Target
More informationThe Clorox Company NEUTRAL ZACKS CONSENSUS ESTIMATES (CLX-NYSE)
March 11, 2015 The Clorox Company Current Recommendation NEUTRAL Prior Recommendation Outperform Date of Last Change 11/11/2012 Current Price (03/10/15) $107.83 Target Price $113.00 SUMMARY DATA (CLX-NYSE)
More informationMarathon Petroleum Corporation
January 19, 2015 Marathon Petroleum Corporation (MPC-NYSE) Current Recommendation SUMMARY DATA NEUTRAL Prior Recommendation Underperform Date of Last Change 01/07/2014 Current Price (01/16/15) $77.56 Target
More informationUltra Petroleum Corp.
January 21, 2015 Ultra Petroleum Corp. Current Recommendation Prior Recommendation Neutral Date of Last Change 11/16/2014 Current Price (01/20/15) $13.57 Target Price $12.00 SUMMARY DATA UNDERPERFORM 52-Week
More informationEquity Residential NEUTRAL ZACKS CONSENSUS ESTIMATES (EQR-NYSE) SUMMARY
March 16, 2015 Equity Residential Current Recommendation SUMMARY DATA NEUTRAL Prior Recommendation Outperform Date of Last Change 11/15/2009 Current Price (03/13/15) $77.02 Target Price $81.00 52-Week
More informationKB Home UNDERPERFORM ZACKS CONSENSUS ESTIMATES (KBH-NYSE)
February 11, 2015 KB Home (KBH-NYSE) Current Recommendation Prior Recommendation Neutral Date of Last Change 02/11/2015 Current Price (02/10/15) $13.61 Target Price $12.00 UNDERPERFORM SUMMARY We are downgrading
More informationLiberty Interactive Corporation
September 11, 2014 Liberty Interactive Corporation (LINTA-NASDAQ) Current Recommendation Prior Recommendation Neutral Date of Last Change 09/11/2014 Current Price (09/10/14) $29.41 Target Price $27.00
More informationTerex Corporation NEUTRAL ZACKS CONSENSUS ESTIMATES (TEX-NYSE) SUMMARY
February 19, 2015 Terex Corporation Current Recommendation SUMMARY DATA NEUTRAL Prior Recommendation Underperform Date of Last Change 01/04/2015 Current Price (02/18/15) $26.80 Target Price $28.00 52-Week
More informationAvon Products Inc. UNDERPERFORM ZACKS CONSENSUS ESTIMATES (AVP-NYSE)
February 19, 2015 Avon Products Inc. Current Recommendation Prior Recommendation Neutral Date of Last Change 02/19/2015 Current Price (02/18/15) $9.10 Target Price $8.25 SUMMARY DATA UNDERPERFORM 52-Week
More informationHSBC Holdings plc ADR (HSBC-NYSE)
February 24, 2015 HSBC Holdings plc ADR (HSBC-NYSE) Analyst Note NEUTRAL Current Recommendation Prior Recommendation Outperform Date of Last Change 12/21/2014 Current Price (02/23/15) $44.68 Target Price
More informationPenske Automotive Group, Inc. (PAG-NYSE)
February 13, 2015 Penske Automotive Group, Inc. (PAG-NYSE) Current Recommendation Prior Recommendation Neutral Date of Last Change 07/16/2014 Current Price (02/12/15) $47.96 Target Price $58.00 SUMMARY
More informationItron, Inc. UNDERPERFORM ZACKS CONSENSUS ESTIMATES (ITRI-NASDAQ) SUMMARY
February 13, 2015 Itron, Inc. Current Recommendation Prior Recommendation Neutral Date of Last Change 02/08/2015 Current Price (02/12/15) $35.87 Target Price $33.00 SUMMARY DATA UNDERPERFORM 52-Week High
More informationThe Tjx Companies Inc
February 26, 2015 The Tjx Companies Inc Current Recommendation Prior Recommendation Underperform Date of Last Change 04/29/2010 Current Price (02/25/15) $69.38 Target Price $73.00 NEUTRAL SUMMARY (TJX-NYSE)
More informationHudson City Bancorp, Inc.
March 20, 2015 Hudson City Bancorp, Inc. Current Recommendation SUMMARY DATA NEUTRAL Prior Recommendation Outperform Date of Last Change 03/20/2015 Current Price (03/19/15) $10.31 Target Price $11.00 52-Week
More informationDENTSPLY International Inc.
March 18, 2015 DENTSPLY International Inc. Current Recommendation Prior Recommendation NEUTRAL Outperform Date of Last Change 02/19/2012 Current Price (03/17/15) $51.13 Target Price $54.00 SUMMARY (XRAY-NASDAQ)
More informationCRA International Inc.
February 27, 2015 CRA International Inc. Current Recommendation Prior Recommendation Outperform Date of Last Change 02/09/2015 Current Price (02/26/15) $30.11 Target Price $32.00 NEUTRAL (CRAI-NASDAQ)
More informationPrecision Castparts Corp.
February 19, 2015 Precision Castparts Corp. Current Recommendation Prior Recommendation Neutral Date of Last Change 02/19/2015 Current Price (02/18/15) $210.97 Target Price $192.00 UNDERPERFORM (PCP-NYSE)
More informationDover Corporation NEUTRAL ZACKS CONSENSUS ESTIMATES (DOV-NYSE) SUMMARY
March 09, 2015 Dover Corporation Current Recommendation Prior Recommendation Outperform Date of Last Change 01/11/2011 Current Price (03/06/15) $70.71 Target Price $74.00 NEUTRAL SUMMARY (DOV-NYSE) In
More informationDillard s Inc. NEUTRAL ZACKS CONSENSUS ESTIMATES (DDS-NYSE)
March 12, 2015 Dillard s Inc. Current Recommendation SUMMARY DATA NEUTRAL Prior Recommendation Outperform Date of Last Change 01/05/2014 Current Price (03/11/15) $130.28 Target Price $137.00 52-Week High
More informationAvnet, Inc. NEUTRAL ZACKS CONSENSUS ESTIMATES (AVT-NYSE) SUMMARY
January 30, 2015 Avnet, Inc. Current Recommendation Prior Recommendation SUMMARY DATA NEUTRAL Underperform Date of Last Change 04/02/2013 Current Price (01/29/15) $42.26 Target Price $44.00 52-Week High
More informationJones Lang LaSalle Inc.
February 13, 2015 Jones Lang LaSalle Inc. Current Recommendation SUMMARY DATA NEUTRAL Prior Recommendation Underperform Date of Last Change 11/07/2013 Current Price (02/12/15) $160.97 Target Price $169.00
More informationInterpublic Group of Companies Inc.
February 16, 2015 Interpublic Group of Companies Inc. (IPG-NYSE) Current Recommendation SUMMARY DATA NEUTRAL Prior Recommendation Outperform Date of Last Change 05/28/2012 Current Price (02/13/15) $22.10
More informationSUMMARY. Risk Level *
February 13, 2015 NetApp, Inc. Current Recommendation Earnings Update: NetApp Reports Q3 Results SUMMARY DATA NEUTRAL Prior Recommendation Outperform Date of Last Change 08/19/2013 Current Price (02/12/15)
More informationCONSOL Energy Inc. (CNX-NYSE)
March 17, 2015 CONSOL Energy Inc. (CNX-NYSE) Current Recommendation NEUTRAL Prior Recommendation Underperform Date of Last Change 08/20/2013 Current Price (03/16/15) $27.02 Target Price $28.00 SUMMARY
More informationSuncor Energy UNDERPERFORM ZACKS CONSENSUS ESTIMATES (SU-NYSE)
March 11, 2015 Suncor Energy (SU-NYSE) Current Recommendation Prior Recommendation Neutral Date of Last Change 12/18/2014 Current Price (03/10/15) $28.03 Target Price $25.00 UNDERPERFORM SUMMARY Amid weak
More informationBig Lots Inc. NEUTRAL ZACKS CONSENSUS ESTIMATES (BIG-NYSE) SUMMARY
March 13, 2015 Big Lots Inc. Current Recommendation SUMMARY DATA NEUTRAL Prior Recommendation Underperform Date of Last Change 03/24/2014 Current Price (03/11/15) $49.95 Target Price $52.00 52-Week High
More informationAmerican Axle & Manufacturing Holdings Inc.
January 22, 2015 American Axle & Manufacturing Holdings Inc. (AXL-NYSE) NEUTRAL Current Recommendation Prior Recommendation Underperform Date of Last Change 05/07/2013 Current Price (01/21/15) $24.14 Target
More informationTransocean Ltd. NEUTRAL ZACKS CONSENSUS ESTIMATES (RIG-NYSE)
January 14, 2015 Transocean Ltd. (RIG-NYSE) Current Recommendation Prior Recommendation Underperform Date of Last Change 02/14/2012 Current Price (01/13/15) $15.52 Target Price $16.00 NEUTRAL SUMMARY We
More informationThe PNC Financial Services Group, Inc.
February 16, 2015 The PNC Financial Services Group, Inc. (PNC-NYSE) Current Recommendation Prior Recommendation Outperform Date of Last Change 05/04/2010 Current Price (02/13/15) $92.38 Target Price $97.00
More informationLincoln Electric Holdings Inc.
January 22, 2015 Lincoln Electric Holdings Inc. Current Recommendation Prior Recommendation Neutral Date of Last Change 01/22/2015 Current Price (01/21/15) $67.15 Target Price $81.00 OUTPERFORM SUMMARY
More informationBancorpSouth, Inc. NEUTRAL ZACKS CONSENSUS ESTIMATES (BXS-NYSE) SUMMARY
December 22, 2014 BancorpSouth, Inc. Current Recommendation Prior Recommendation Outperform Date of Last Change 09/23/2013 Current Price (12/19/14) $22.12 Target Price $23.00 NEUTRAL SUMMARY (BXS-NYSE)
More informationExelon Corporation NEUTRAL ZACKS CONSENSUS ESTIMATES (EXC-NYSE) SUMMARY
March 06, 2015 Exelon Corporation Current Recommendation Prior Recommendation NEUTRAL Underperform Date of Last Change 06/28/2009 Current Price (03/05/15) $32.97 Target Price $35.00 (EXC-NYSE) SUMMARY
More informationSymmetry Medical, Inc.
November 28, 2014 Symmetry Medical, Inc. Current Recommendation SUMMARY DATA NEUTRAL Prior Recommendation Outperform Date of Last Change 11/28/2014 Current Price (11/27/14) $9.11 Target Price $9.50 52-Week
More informationNuStar Energy, L.P. NEUTRAL ZACKS CONSENSUS ESTIMATES (NS-NYSE) SUMMARY
March 13, 2015 NuStar Energy, L.P. Current Recommendation Prior Recommendation Underperform Date of Last Change 09/26/2013 Current Price (03/12/15) $60.71 Target Price $63.00 NEUTRAL SUMMARY (NS-NYSE)
More informationFlowserve Corporation
March 17, 2015 Flowserve Corporation Current Recommendation Prior Recommendation Underperform Date of Last Change 12/18/2014 Current Price (03/16/15) $56.96 Target Price $60.00 NEUTRAL (FLS-NYSE) SUMMARY
More informationMeritor, Inc. OUTPERFORM ZACKS CONSENSUS ESTIMATES (MTOR-NYSE)
January 08, 2015 Meritor, Inc. Current Recommendation Prior Recommendation Neutral Date of Last Change 01/08/2015 Current Price (01/07/15) $15.10 Target Price $18.00 SUMMARY DATA OUTPERFORM 52-Week High
More informationRockwell Automation Inc.
March 16, 2015 Rockwell Automation Inc. Current Recommendation SUMMARY DATA NEUTRAL Prior Recommendation Outperform Date of Last Change 07/31/2011 Current Price (03/13/15) $111.52 Target Price $117.00
More informationAGCO Corporation NEUTRAL ZACKS CONSENSUS ESTIMATES (AGCO-NYSE) SUMMARY
February 05, 2015 AGCO Corporation Current Recommendation SUMMARY DATA NEUTRAL Prior Recommendation Underperform Date of Last Change 12/28/2014 Current Price (02/03/15) $48.96 Target Price $51.00 52-Week
More informationBed Bath & Beyond Inc.
January 21, 2015 Bed Bath & Beyond Inc. Current Recommendation SUMMARY DATA NEUTRAL Prior Recommendation Outperform Date of Last Change 11/23/2009 Current Price (01/20/15) $73.31 Target Price $77.00 52-Week
More informationSUMMARY. Risk Level *
January 09, 2015 Fred s Inc (FRED-NASDAQ) Current Recommendation SUMMARY DATA NEUTRAL Prior Recommendation Underperform Date of Last Change 07/17/2014 Current Price (01/08/15) $17.13 Target Price $18.00
More informationPlum Creek Timber Co. Inc.
February 19, 2015 Plum Creek Timber Co. Inc. Current Recommendation Prior Recommendation Underperform Date of Last Change 11/23/2014 Current Price (02/18/15) $43.04 Target Price $45.00 NEUTRAL (PCL-NYSE)
More informationCanadian Natural Resources Ltd.
September 11, 2009 Canadian Natural Resources Ltd. SUMMARY DATA NEUTRAL Current Recommendation Prior Recommendation OUTPERFORM Date of Last Change 08/18/2009 Current Price (09/10/09) $62.91 Target Price
More informationLiberty Property Trust
December 29, 2014 Liberty Property Trust Current Recommendation SUMMARY DATA NEUTRAL Prior Recommendation Underperform Date of Last Change 01/27/2014 Current Price (12/26/14) $37.95 Target Price $40.00
More informationCablevision Systems Corporation.
January 14, 2015 Cablevision Systems Corporation. Current Recommendation SUMMARY DATA NEUTRAL Prior Recommendation Outperform Date of Last Change 02/10/2014 Current Price (01/13/15) $20.00 Target Price
More informationNavigant Consulting Inc.
February 17, 2015 Navigant Consulting Inc. Current Recommendation SUMMARY DATA NEUTRAL Prior Recommendation Outperform Date of Last Change 08/15/2013 Current Price (02/16/15) $14.99 Target Price $16.00
More informationMcDermott International Inc.
January 12, 2015 McDermott International Inc. Current Recommendation NEUTRAL Prior Recommendation Underperform Date of Last Change 03/04/2013 Current Price (01/09/15) $2.85 Target Price $3.00 SUMMARY DATA
More informationCompanhia Paranaense De Energia
January 21, 2015 Companhia Paranaense De Energia (ELP-NYSE) Current Recommendation SUMMARY DATA NEUTRAL Prior Recommendation Underperform Date of Last Change 01/21/2015 Current Price (01/20/15) $12.20
More information(MOS-NYSE) Risk Level *
March 09, 2015 The Mosaic Company Current Recommendation Prior Recommendation Neutral Date of Last Change 03/09/2015 Current Price (03/06/15) $49.03 Target Price $59.00 OUTPERFORM (MOS-NYSE) SUMMARY We
More informationDollar General Corporation
March 19, 2015 Dollar General Corporation Current Recommendation SUMMARY DATA NEUTRAL Prior Recommendation Outperform Date of Last Change 11/09/2011 Current Price (03/18/15) $75.39 Target Price $79.00
More informationSallie Mae NEUTRAL ZACKS CONSENSUS ESTIMATES (SLM-NASDAQ)
December 30, 2014 Sallie Mae (SLM-NASDAQ) Current Recommendation SUMMARY DATA NEUTRAL Prior Recommendation Outperform Date of Last Change 01/08/2013 Current Price (12/29/14) $10.32 Target Price $11.00
More informationKirkland s Inc OUTPERFORM ZACKS CONSENSUS ESTIMATES (KIRK-NASDAQ) SUMMARY
February 09, 2015 Kirkland s Inc (KIRK-NASDAQ) Current Recommendation Prior Recommendation Neutral Date of Last Change 02/09/2015 Current Price (02/06/15) $25.66 Target Price $31.00 OUTPERFORM SUMMARY
More informationCabot Oil & Gas Corporation
January 16, 2015 Cabot Oil & Gas Corporation Current Recommendation Prior Recommendation Neutral Date of Last Change 01/16/2015 Current Price (01/15/15) $28.78 Target Price $26.00 UNDERPERFORM SUMMARY
More informationThe Cheesecake Factory Incorporated
March 20, 2015 The Cheesecake Factory Incorporated (CAKE-NASDAQ) Current Recommendation SUMMARY DATA NEUTRAL Prior Recommendation Outperform Date of Last Change 01/12/2011 Current Price (03/19/15) $48.82
More informationInteractive Brokers Group, Inc.
January 06, 2015 Interactive Brokers Group, Inc. (IBKR-NASDAQ) Current Recommendation NEUTRAL Prior Recommendation Outperform Date of Last Change 07/08/2014 Current Price (01/05/15) $28.88 Target Price
More informationBorgWarner Inc. NEUTRAL ZACKS CONSENSUS ESTIMATES (BWA-NYSE)
February 13, 2015 BorgWarner Inc. Current Recommendation Prior Recommendation Underperform Date of Last Change 03/24/2013 Current Price (02/12/15) $61.38 Target Price $64.00 NEUTRAL (BWA-NYSE) SUMMARY
More informationUnited Parcel Service Inc.
December 25, 2014 United Parcel Service Inc. Current Recommendation SUMMARY DATA NEUTRAL Prior Recommendation Outperform Date of Last Change 02/04/2009 Current Price (12/24/14) $112.41 Target Price $118.00
More informationAllscripts Healthcare Solutions, Inc.
December 01, 2014 Allscripts Healthcare Solutions, Inc. Current Recommendation Prior Recommendation SUMMARY DATA NEUTRAL Outperform Date of Last Change 05/17/2012 Current Price (11/28/14) $12.02 Target
More informationSinopec Shanghai Petrochemical Co. Ltd.
March 18, 2013 Sinopec Shanghai Petrochemical Co. Ltd. (SHI-NYSE) NEUTRAL Current Recommendation Prior Recommendation Outperform Date of Last Change 06/10/2008 Current Price (03/15/13) $42.10 Target Price
More informationO'Reilly Automotive Inc.
February 05, 2015 O'Reilly Automotive Inc. Current Recommendation SUMMARY DATA NEUTRAL Prior Recommendation Outperform Date of Last Change 06/15/2011 Current Price (02/03/15) $193.28 Target Price $203.00
More information(L-NYSE) SUMMARY. Risk Level *
February 10, 2015 Loews Corporation Current Recommendation SUMMARY DATA NEUTRAL Prior Recommendation Underperform Date of Last Change 09/04/2014 Current Price (02/09/15) $41.23 Target Price $43.00 52-Week
More informationLegg Mason Inc. NEUTRAL ZACKS CONSENSUS ESTIMATES (LM-NYSE)
March 12, 2015 Legg Mason Inc. Current Recommendation SUMMARY DATA NEUTRAL Prior Recommendation Underperform Date of Last Change 09/22/2013 Current Price (03/11/15) $55.03 Target Price $58.00 52-Week High
More informationSUMMARY. Risk Level *
February 02, 2015 Xerox Corporation Current Recommendation SUMMARY DATA NEUTRAL Prior Recommendation Underperform Date of Last Change 10/18/2012 Current Price (01/30/15) $13.17 Target Price $14.00 52-Week
More informationArmstrong World Industries, Inc.
December 11, 2014 Armstrong World Industries, Inc. (AWI-NYSE) Current Recommendation Prior Recommendation Neutral Date of Last Change 08/24/2014 Current Price (12/10/14) $47.71 Target Price $43.00 SUMMARY
More informationCentral Garden & Pet Company
February 11, 2015 Central Garden & Pet Company (CENT-NASDAQ) Current Recommendation SUMMARY DATA NEUTRAL Prior Recommendation Outperform Date of Last Change 06/22/2014 Current Price (02/10/15) $9.13 Target
More informationDeere & Company NEUTRAL ZACKS CONSENSUS ESTIMATES (DE-NYSE)
February 13, 2015 Deere & Company Current Recommendation Prior Recommendation Outperform Date of Last Change 12/09/2010 Current Price (02/12/15) $89.37 Target Price $94.00 NEUTRAL (DE-NYSE) SUMMARY Deere
More informationSnap-On Inc. NEUTRAL ZACKS CONSENSUS ESTIMATES RECENT NEWS (SNA-NYSE) SUMMARY
February 09, 2015 Snap-On Inc. (SNA-NYSE) NEUTRAL Current Recommendation Prior Recommendation Outperform Date of Last Change 09/26/2011 Current Price (02/06/15) $140.99 Target Price $148.00 SUMMARY Keeping
More informationUbiquiti Networks, Inc.
January 07, 2015 Ubiquiti Networks, Inc. Current Recommendation Prior Recommendation Neutral Date of Last Change 01/07/ 2015 Current Price (01/06/15) $27.86 Target Price $25.00 UNDERPERFORM (UBNT-NASDAQ)
More informationHealth Care REIT Inc.
January 05, 2015 Health Care REIT Inc. Current Recommendation SUMMARY DATA NEUTRAL Prior Recommendation Underperform Date of Last Change 07/20/2004 Current Price (01/02/15) $76.95 Target Price $81.00 52-Week
More informationThe Valspar Corporation
March 04, 2015 The Valspar Corporation Current Recommendation Prior Recommendation Outperform Date of Last Change 07/05/2012 Current Price (03/03/15) $87.26 Target Price $92.00 NEUTRAL (VAL-NYSE) SUMMARY
More informationFrontier Communications Corporation
January 20, 2015 Frontier Communications Corporation Current Recommendation SUMMARY DATA NEUTRAL Prior Recommendation Underperform Date of Last Change 02/27/2006 Current Price (01/19/15) $6.83 Target Price
More informationNike Inc. NEUTRAL ZACKS CONSENSUS ESTIMATES (NKE-NYSE)
December 31, 2014 Nike Inc. Current Recommendation SUMMARY DATA NEUTRAL Prior Recommendation Outperform Date of Last Change 12/31/2014 Current Price (12/30/14) $96.88 Target Price $102.00 52-Week High
More informationathenahealth Inc. NEUTRAL ZACKS CONSENSUS ESTIMATES (ATHN-NASDAQ) SUMMARY
February 10, 2015 athenahealth Inc. Current Recommendation SUMMARY DATA NEUTRAL Prior Recommendation Outperform Date of Last Change 10/23/2011 Current Price (02/09/15) $136.28 Target Price $143.00 52-Week
More informationVeriSign Inc. NEUTRAL ZACKS CONSENSUS ESTIMATES (VRSN-NASDAQ) SUMMARY
September 19, 2013 VeriSign Inc. Current Recommendation Prior Recommendation SUMMARY DATA NEUTRAL Outperform Date of Last Change 06/24/2013 Current Price (09/18/13) $51.30 Target Price $54.00 52-Week High
More informationTC PipeLines, L.P. (TCP-NYSE)
February 16, 2015 TC PipeLines, L.P. (TCP-NYSE) NEUTRAL Current Recommendation Prior Recommendation Outperform Date of Last Change 09/23/2014 Current Price (02/13/15) $68.99 Target Price $72.00 SUMMARY
More information